Cellebrite DI (CLBT) Non-Current Deffered Revenue: 2020-2025

Historic Non-Current Deffered Revenue for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $239.7 million.

  • Cellebrite DI's Non-Current Deffered Revenue rose 15.96% to $239.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.7 million, marking a year-over-year increase of 15.96%. This contributed to the annual value of $45.2 million for FY2024, which is 3.93% down from last year.
  • Latest data reveals that Cellebrite DI reported Non-Current Deffered Revenue of $239.7 million as of Q3 2025, which was up 5.50% from $227.2 million recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Non-Current Deffered Revenue peaked at $239.7 million during Q3 2025, and registered a low of $36,426 during Q2 2021.
  • For the 3-year period, Cellebrite DI's Non-Current Deffered Revenue averaged around $153.1 million, with its median value being $183.9 million (2024).
  • Per our database at Business Quant, Cellebrite DI's Non-Current Deffered Revenue plummeted by 99.96% in 2023 and then surged by 390,443.12% in 2024.
  • Cellebrite DI's Non-Current Deffered Revenue (Quarterly) stood at $36.4 million in 2021, then rose by 15.78% to $42.2 million in 2022, then climbed by 11.68% to $47.1 million in 2023, then declined by 3.93% to $45.2 million in 2024, then rose by 15.96% to $239.7 million in 2025.
  • Its Non-Current Deffered Revenue stands at $239.7 million for Q3 2025, versus $227.2 million for Q2 2025 and $219.4 million for Q1 2025.